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Increasing arteriovenous fistulas in hemodialysis patients: [1, 2]. In an effort to improve vascular access outcomes
Problems and solutions. National guidelines promote increas- the National Kidney Foundation published the Dialysis
ing the prevalence of fistula use among hemodialysis patients. Outcome Quality Initiative (DOQI) guidelines in 1997,The prevalence of fistulas among hemodialysis patients reflects
a set of evidence-based and opinion-based guidelines re-both national, regional, and local practice differences as well
garding the optimal management of vascular access [3].as patient-specific demographic and clinical factors. Increasing
fistula prevalence requires increasing fistula placement, im- The DOQI guidelines have stimulated a large body of
proving maturation of new fistulas, and enhancing long-term epidemiologic and clinical studies on vascular access,
patency of mature fistulas for dialysis. Whether a patient re-
thereby expanding our understanding of this importantceives a fistula depends on several factors: timing of referral
topic. One important DOQI guideline has urged nephrol-for dialysis and vascular access, type of fistula placed, patient
demographics, preference of the nephrologist, surgeon, and ogists to increase the number of patients dialyzing with
dialysis nurses, and vascular anatomy of the patient. Whether arteriovenous (A-V) fistulas, rather than grafts. The pres-
the placed fistula is useable for dialysis depends on additional ent review summarizes recent clinical research that helpsfactors, including adequacy of vessels, surgeon’s experience,
us understand how to achieve this important goal.patient demographics, nursing skills, minimal acceptable dial-
ysis blood flow, and attempts to revise immature fistulas.
Whether a mature fistula achieves long-term patency depends
WHAT IS THE RATIONALE FOR INCREASINGon the ability to prevent and correct thrombosis. An optimal
outcome is likely when there is (1) a multidisciplinary team FISTULA PLACEMENT?
approach to vascular access; (2) consensus about the goals
The relative merits of A-V fistulas and grafts haveamong all interested parties (nephrologists, surgeons, radiolo-
been a subject of ongoing investigation and debate forgists, dialysis nurses, and patients); (3) early referral for place-
ment of vascular access; (4) restriction of vascular access proce- many years. Thirty years ago, patient selection for dial-
dures to surgeons with demonstrable interest and experience; ysis was relatively stringent, and most patients were
(5) routine, preoperative mapping of the patient’s arteries and young, non-diabetic men with minimal co-morbidity (Ta-
veins; (6) close, ongoing communication among the involved
ble 1). Within this select population, the arteries andparties; and (7) prospective tracking of outcomes with continu-
veins were generally well preserved and permitted con-ous quality assessment. Implementing these measures is likely
to increase the prevalence of fistulas in any given dialysis unit. struction of native A-V fistulas in the wrist. The expecta-
However, differences among dialysis units are likely to persist tion was that the vast majority of fistulas placed would
because of differences in gender, race, and co-morbidity mix
mature adequately to be used for dialysis, and subse-of the patient population.
quently remain patent and useable for dialysis for many
years with minimal intervention. In addition, up until the
mid-1980s the median dialysis blood flow in the UnitedVascular access procedures and complications account
States was about 250 mL/min [4], such that even rela-for over 20% of hospitalizations of dialysis patients in
tively small diameter fistulas could deliver the desiredthe United States and cost about $1 billion annually
flows.
In recent years, as a result of more liberal selection
Key words: preoperative vascular mapping, graft placement, hemodial-
criteria, the chronic dialysis population has become sub-ysis, end-stage renal disease, thrombosis, dialysis blood flow, vascular
access, A-V fistula. stantially older, more likely to be female and diabetic,
and has higher co-morbidity, including extensive athero-
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Table 1. Hemodialysis patient characteristics in the United States (1967 and 1999) and in Europe (1999)
1967 (US) 1999 (US) 1999 (Europe) P valuea
Female gender % 25 47 43 0.03
Black race % 9 38 1 0.001
Age, meanSD 60.515.5 60.715.2 NS
Age 65 years % 7 50
Diabetes % 5 46 22 0.001
Coronary artery disease % 26 51 31 0.001
Cerebrovascular disease % 19 13.5 0.001
Peripheral vascular disease % 23 19 0.005
Congestive heart failure 48 23 0.001
U.S. data for 1967 are adapted from [60] and [61]. U.S. and European data for 1999 are adapted from [18] and Goodkin et al (abstract, J Am Soc Nephrol 10:
242A, 1999). NS is not significant.
a Comparison between United States and Europe in 1999
Table 2. Short-term outcomes of fistulasysis adequacy (Kt/V) has led to the recognition that
higher blood flows can improve urea clearance, and Primary
(unassisted)thereby permit delivery of adequate dialysis to larger
Primary survival atpatients without entailing substantial increases in dialysis N accesses failures % 1 year %
times. These considerations have led to increased utiliza-
Citation Fistula Graft Fistula Graft Fistula Graft
tion of A-V grafts and decreased use of A-V fistulas. By
Kinnaert, 1977 [62] 314 9 80the mid-1990s only 20% of patients in the United States Bonalumi, 1982 [63] 177 10 83
were dialyzing with fistulas [5]. Reilly, 1982 [64] 150 11 80
Palder, 1985 [65] 154 24With the growing use of A-V grafts, it became evident
Winsett, 1985 [66] 273 27that the prosthetic vascular access is prone to an alarming Kherlakian, 1986 [21] 100 100 12 4 71 75
Churchill, 1992 [67] 227 120 82-87 45-67frequency of thrombosis [6]. Further investigation led to
Coburn, 1994 [20] 59 47 90 70the observation that graft thrombosis usually arises from
Rocco, 1996 [23] 48 40 31 12 55 60
progressive stenosis at the venous anastomosis or the Wong, 1996 [48] 60 30
Miller, 1997 [34] 75 23 84 47draining vein, and that prophylactic angioplasty of ste-
Hodges, 1997 [68] 87 236 43 43 41notic lesions decreases the frequency of graft thrombosis
Silva, 1998 [51] 108 26 83 74
substantially [7–11]. Recognition of the value of elective Hakaim, 1998 [38] 58 22
Golledge, 1999 [69] 107 18 69angioplasty led to considerable research on monitoring
Miller, 1999 [25] 101 53methods for detection of hemodynamically significant Konner, 2000 [70] 347 2 77
graft stenosis [2]. Nonetheless, it became clear that graft Ascher, 2000 [52] 99 18
Murphy, 2000 [71] 74 32stenosis is a frequent and recurrent process, and that
Renavur, 2000 [72] 137 22 74monitoring and intervention to prevent graft thrombosis Wolowczyk, 2000 [45] 208 20 65
is costly and labor intensive [2]. Gibson, 2001 [35] 130 92 23 56 36
Allon, 2001 [13] 139 78 46 21 42 43Arteriovenous fistulas once again came into favor due
Oliver, 2001 [12] 115 80 26 15 65 47to their lower frequency of stenosis, thrombosis, and Sedlacek, 2001 [43] 140 25
infection, as compared to A-V grafts. In this context, the Dixon, 2002 [26] 205 117 30 23 53 27
Pisoni, 2002 [18] 177 251 68 49DOQI vascular access guidelines advocated intensive
Primary failure is defined as thrombosis or failure to mature adequately forefforts to increase the prevalence of fistula use among
dialysis, while primary survival is time from access placement to initial intervention.
dialysis patients [3]. These guidelines recommend at-
tempting fistula placement in at least 50% of patients,
with A-V grafts being reserved for patients whose vascu-
lar anatomy does not permit construction of a native creases the frequency of primary failure. Whereas studies
A-V fistula. DOQI guidelines predict that such a strategy from 20 to 25 years ago observed a primary fistula failure
will result in 40% of prevalent patients dialyzing with a rate of about 10%, more recent investigations have typi-
fistula. cally reported a 20 to 50% primary failure rate (Table
A major hurdle in achieving this goal is the high fre- 2). The primary (intervention-free) survival of fistulas at
quency of new A-V fistulas that are never useable for one year was better than that of grafts in some studies,
dialysis (primary failures) either due to early thrombosis but not in others (Table 2). These comparisons are often
or due to lack of maturation. A deliberate policy of misleading, because some investigators have specifically
placing A-V fistulas in the majority of dialysis patients, excluded fistulas that never matured, whereas others
have included primary failures, when calculating primarymany of whom have marginal vessels, necessarily in-
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Table 3. Long-term outcomes of arteriovenous (A-V) fistulas versus grafts
Cumulative survival at 1 year % Revision rate per access-year Infection rate %
Citation F G Ratio (G/F) F G Ratio (G/F) F G Ratio (G/F)
Winsett, 1985 [66] 0.06 0.44 7.3 1 12 12
Palder, 1985 [65] 63 82 1.30 22
Kherlakian, 1986 [21] 2 12 6.0
Churchill, 1992 [67] 4.5 19.7 4.4
Coburn, 1994 [20] 87 64 0.74 3.4 16.1 4.7
Rocco, 1996 [23] 78 88 1.13 0.34 0.80 2.4 0 6.2
Miller, 1997 [34] 83 73 0.88 0.17 1.17 6.9
Hodges, 1997 [68] 46 59 1.28 0.07 0.50 7.1 0 9
Gibson, 2001 [35] 72 58 0.80 2.9
Oliver, 2001 [12] 65 68 1.05 0.55 2.4 4.4 2 12 6.0
Allon, 2001 [13] 44 48 1.09 0.57 1.67 2.9
McCarley, 2001 [11] 0.18 0.80 4.4
Dixon, 2002 [26] 61 54 0.88 0.45 1.80 4.0
Only studies reporting outcomes of both fistulas and grafts have been included. Abbreviations are: F, fistula; G, graft. Cumulative survival is defined as time from
access placement to permanent failure of access despite revisions; revision rate is angioplasty, thrombectomy, and surgical revisions.
patency. Given the higher rates of non-maturation of
fistulas as compared with grafts, the two types of calcula-
tions lead to different conclusions. Thus, for example,
Oliver et al reported that the primary patency of fistulas
was superior to that of grafts, when primary failures were
excluded [12]. However, when primary failures were in-
cluded, the primary patency of fistulas and grafts was
comparable during the initial year.
Similarly, studies comparing the cumulative survival
(time from access placement to permanent failure) at
one year of fistulas and grafts have yielded contradictory
results (Table 3). Again, these discrepancies can be at-
tributed to discrepancies in the primary failure rates of
fistulas as compared with grafts, as well as whether pri-
mary access failures were included in the calculations of
access survival. Oliver et al reported that, when primary
failures were excluded, the cumulative patency of fistulas
was superior to that of grafts [12]. However, when pri-
mary failures were included, the cumulative patency of
fistulas and grafts was comparable at one year (Fig. 1).
The equivalent outcome occurred because the higher
primary failure rate of fistulas was offset by the lower
rate of subsequent failures. Similar observations on the
Fig. 1. Failure-free survival (cumulative patency) of brachiobasilic
relative short- and long-term outcomes of fistulas and fistulas (dotted line), brachiocephalic fistulas (dashed line), and
upper arm grafts (solid line) excluding (A ) and including primarygrafts have been reported by our institution [13].
failure (B ). When primary failures are excluded, survival of brachio-Despite the comparable cumulative survival of fistulas cephalic and brachiobasilic fistulas are comparable to each other,
and grafts, the major advantage of fistulas over grafts is and both are better than for grafts. When primary failures are
included, the survival rates for all three types of vascular access arethe lower frequency of interventions and complications,
comparable. (Reproduced with permission from the International
once they mature. Maintaining long-term graft patency Society of Nephrology [12].)
requires a 2.4- to 7.1-fold higher frequency of salvage
procedures (angioplasty, thrombectomy, and surgical re-
vision; Table 3). Moreover, access infections occur sub-
payoff, however, is prolonged patency with far fewerstantially more frequently in grafts as compared to fistu-
interventions, complications, and expenditures.las (Table 3). In the short-term, placing a fistula requires
A major clinical challenge is to optimize the approacha greater investment, due to the higher primary failure
rate and much longer time to maturation. The long-term to constructing A-V fistulas, so as to maximize the pro-
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portion of patients receiving a fistula while minimizing level of the surgeons, nephrologists, and dialysis unit
staff. One study reported that in 35% of U.S. dialysisthe proportion of fistulas that never mature. The goal
of the present review is to examine critically the reasons units the dialysis staff preferred grafts over fistulas [19].
underlying the discrepancy between the goals and reality.
Patient factorsSpecifically, we will examine the clinical and logistic ob-
stacles to increasing the prevalence of fistulas among Several demographic and clinical factors have been
hemodialysis patients. We will also address specific mea- associated with a lower prevalence of fistulas, even after
sures that have been documented to improve vascular adjustment for geographic region and dialysis unit. Nu-
access outcomes at selected institutions. merous studies have reported that female patients are
much less likely than males to dialyze with a fistula [14,
15, 18, 20–23]. The 2000 Annual Report of ESRD Clini-
WHAT FACTORS AFFECT FISTULA cal Performance Measures found that nationwide, the
PREVALENCE IN DIALYSIS PATIENTS? prevalence of fistulas among women was only 18%, as
Geographic variations compared to 35% in men (Fig. 3) [16]. This discrepancy
between the genders was observed in each of the 18 U.S.Practice patterns can have a major impact on the prev-
networks.alence of patients dialyzing with fistulas. In a landmark
Similarly, a number of recent studies have observedstudy Hirth et al reported substantial geographic varia-
a lower prevalence of fistulas used for dialysis amongtions in the prevalence of fistulas among new dialysis
blacks than whites [12, 15, 23, 24]. Hirth et al did notpatients within the United States, ranging from a high
observe a difference in the frequency of fistulas betweenof 77% in New England to a low of 15% in the Southeast
black and white dialysis patients [14]. However, they[14]. Similarly, analysis of a cohort of 1824 patients en-
reported the type of vascular access present in the pa-rolled in the HEMO Study at 45 American dialysis units
tient’s arm 30 days after initiation of dialysis, regardlessfound substantial geographic variations [15]. The preva-
of whether the access was actually useable for dialysis.lence of fistulas was 45.3% in the Northeast, but only
It is unclear whether the prevalence of useable fistulas30.6% in the Southeast. In both reports, these geographic
differed among races. In a recent nationwide survey,differences persisted even after adjustment for multiple
fistulas were being used in 23% of black patients, asdemographic factors and co-morbid conditions. Varia-
compared with 29% of whites (Fig. 4) [16]. Examinationtions in the type of vascular access are also reflected in
of individual U.S. networks revealed a lower prevalencethe 2000 Annual Report of ESRD Clinical Performance
of fistulas in blacks than whites in 15 of the 18 networks.Measures [16]. During the fourth quarter of 1999, 27%
Fistula prevalence was equivalent or slightly higher inof U.S hemodialysis patients were using fistulas. The
blacks than whites in only two networks. A comparisonprevalence of fistulas varied greatly among the 18 net-
was not possible in one network, because its black popu-works, ranging from a low of 15% to a high of 47%.
lation was too small to perform a valid statistical compar-There are also substantial differences among coun-
ison. A recent investigation from the United Kingdomtries. The Dialysis Outcomes and Practice Patterns Study
also observed that black patients were significantly less(DOPPS) [17] reported that only 24% of U.S. patients
likely to dialyze with a fistula than were whites (abstract;were dialyzing with fistulas, as compared with 80%
Fan et al, J Am Soc Nephrol 12:288A, 2001).among dialysis patients in five European countries (Ger-
Age is an additional independent factor associatedmany, France, Italy, Britain, and Spain) [18]. Lower co-
with the prevalence of fistulas [14, 15, 18, 23, 24]. Nation-morbidity among European dialysis patients (Table 1)
wide, the prevalence of fistulas among U.S. hemodialysismay account for some of the difference. However, it is
patients was 35% in adult patients under age 45, 31%likely that variations in practice patterns also play a ma-
in patients aged 45 to 54 years, 26% in patients ages 65jor role.
to 74, and 23% among patients 75 or older [16]. TheVariations in fistula prevalence are not limited to com-
parisons among countries or large geographic regions. inverse relationship between age and frequency of fistula
use was evident in each of the 18 networks.They are also evident when one compares individual
dialysis units within a single metropolitan area (Fig. 2) Diabetes has been associated with a lower prevalence
of fistulas in some studies [14, 18, 24], but not in others[15]. For example, the prevalence of fistulas at five dial-
ysis units in one metropolitan area (Center 11) was 28.6, [15, 23]. Nationwide, only 22% of U.S. diabetic hemodi-
alysis patients were using fistulas, as compared with 30%43.8, 50.0, 58.8, and 76.7%, respectively. Similarly, the
DOPPS Study reported that fistula use varied from 0 to of non-diabetic patients [16]. There is controversy as to
whether diabetes is an independent risk factor for lower87% among individual American dialysis units, and from
39 to 100% among individual European units [18]. Such fistula prevalence [14], or whether it is a marker for
other associated clinical or co-morbid conditions, suchdifferences may reflect the individual preferences or skill
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Fig. 2. Frequency of fistula use among the hemodialysis units in the HEMO Study. The dialysis units are sorted with the 15 clinical centers
with which they are affiliated. The dialysis units in a given clinical center are located in a single metropolitan area. There are large variations
in the prevalence of fistula use among individual dialysis units. (Reproduced with permission from the International Society of Nephrology
[15].)
Fig. 4. Percent of U.S. patients dialyzing with fistulas in October
to December 1999, sorted by patient race and dialysis network.Fig. 3. Percent of U.S. patients dialyzing with fistulas in October
to December 1999, sorted by patient gender and dialysis network. Symbols are: () black patients; () white patients. Overall fistula
prevalence varies greatly among networks, but in nearly each indi-Symbols are: () female patients; () male patients. Overall fistula
prevalence varies greatly among networks, but in each of the 18 vidual network, fistula use is lower among blacks than whites. Net-
work 15 had too few black patients to be included in the analysis.networks, fistula use is lower among women than men. (Adapted
from [16].) (Adapted from [16].)
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as female gender, older age, black race, obesity, and chronic kidney disease are not referred to a nephrologist
presence of peripheral vascular disease [15]. until their renal failure is very advanced. Even among
Other factors that have been associated with a lower those patients with early referral (at least 4 months be-
fistula prevalence include presence of peripheral vascular fore initiation of dialysis), a substantial proportion still
disease [14, 15, 18, 21], obesity [15, 18, 24], and lower do not get a permanent vascular access prior to initiation
socioeconomic status [14]. of dialysis. Arora et al reported that a functioning perma-
nent vascular access at initiation of dialysis is found in
Practice patterns 40% of patients with early referral to a nephrologist, but
Successful, long-term use of a fistula for dialysis re- only 4% of patients with late referral [28]. Moreover,
quires overcoming at least four hurdles. First, the sur- the first vascular access is more likely to be a fistula
geon must be able and willing to place an A-V fistula. than a graft in patients with an early referral than those
Second, the newly constructed fistula must mature suffi- referred late (45 vs. 31%) [29]. Similar observations have
ciently to be cannulated reproducibly with large-bore been reported from Europe. A recent French study
needles and deliver an acceptable dialysis blood flow. noted that among patients with late referral, 73% initi-
Third, the dialysis staff must be proficient in cannulation ated dialysis with a catheter, and only 12% with a fistula.
of fistulas. Finally, the mature fistula must remain patent In contrast, among patients with early referral, 29% initi-
with minimal requirements for further interventions. ated dialysis with a catheter, and 53% with a fistula [30].
Problems occurring at each of these levels can have a At the time of initiation of dialysis, only 15% of U.S.
cumulative negative effect on the overall prevalence of patients use fistulas, as compared with 66% of European
patients dialyzing with fistulas. Increasing fistula preva- patients [18]. Differences in health coverage among
lence requires a clear understanding of the factors contrib- countries may contribute to this discrepancy. Universal
uting to the problem, and aggressive efforts to overcome health coverage, which is common in most European
these roadblocks. The next few sections will address the countries, promotes comprehensive medical care and
specific variables that determine whether a patient re- early referral to nephrologists and surgeons. In contrast,
ceives a fistula, whether the fistula matures, and whether a substantial proportion of patients with chronic kidney
it achieves long-term patency for dialysis. disease in the U.S. do not qualify for health coverage
until they initiate dialysis.
FACTORS AFFECTING FISTULA PLACEMENT
Type of fistula placed
Timing of fistula placement
The original type of fistula described was the radioce-
The mean maturation time of new A-V fistulas is about
phalic fistula (Fig. 5), which involves a direct anastomosistwo to four months [12, 13, 25, 26]. Moreover, patients
of the radial artery and cephalic vein at the wrist [31].whose fistula fails to mature adequately to be used for
Many patients without suitable vessels in the forearmdialysis require subsequent interventions to promote fis-
may be good candidates for construction of a brachio-tula maturation, or alternatively, construction of another
cephalic fistula in the upper arm (Fig. 6). Because thevascular access. If the patient is already on dialysis, fistula
cephalic vein is frequently cannulated in the antecubitalplacement entails prolonged hemodialysis with a tempo-
space for phlebotomy, the resulting stenosis or thrombo-rary dialysis catheter with all its attendant complications,
sis may preclude its use for construction of a fistula.including poor blood flows, frequent thrombosis or mal-
The basilic vein, which runs deeper and is spared fromfunction, and life-threatening bacteremia [27]. Clearly,
phlebotomy, often has a large enough diameter to permitthese issues can be avoided when the fistula has been
its use for fistula construction. However, its depth fromconstructed in a timely fashion in pre-dialysis patients, so
the skin would preclude cannulation of a brachiobasilicthat it is ready for use prior to the need for maintenance
fistula in the native position. To overcome this difficulty,dialysis. In this regard, the DOQI guidelines recommend
the basilic vein can be dissected out and tunneled in thereferring patients for fistula placement when the serum
subcutaneous tissue of the anterior upper arm, easilycreatinine is 4 mg/dL or the creatinine clearance 25
accessible with a dialysis needle (Fig. 7). The inventionmL/min [3].
of the transposed brachiobasilic fistula [32] has furtherAt initiation of dialysis, 66% of U.S patients use a
expanded the proportion of patients in whom construc-catheter, 22% use a graft, and only 12% use a fistula.
tion of a native fistula is feasible. Finally, Polo et alSixty days after initiation of dialysis, 32% still dialyze
recently described construction of a brachiocephalicwith a catheter, 49% with a graft, and 19% with a fistula.
jump graft fistula, whereby a short polytetrafluoroethy-Of those patients who started dialysis with a catheter,
lene (PTFE) segment is tunneled subcutaneously andbut were dialyzing with a permanent access at 60 days,
anastomosed to the brachial artery and cephalic veinonly 25% were using a fistula, whereas 75% had a graft
[24]. Despite the DOQI guidelines, many patients with through two short skin incisions [33]. They reported a
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Fig. 5. Radiocephalic arteriovenous (A-V) fistula. Fig. 6. Brachiocephalic A-V fistula.
primary patency rate of 85% at one year, comparable arm and 37% in the upper arm), whereas only 27%
to that observed with “pure” upper arm fistulas. required grafts [26]. Finally, Gibson et al were able to
The majority of dialysis patients can have a native place an A-V fistula in 95% of patients (almost exclu-
fistula placed as their initial vascular access, provided sively men) [35].
that there is a willingness to consider all three types of The likelihood of placing a secondary fistula among
fistulas, and to use preoperative vascular mapping to patients with at least one failed vascular access is consid-
identify suitable vessels for their construction. Using ob- erably lower. Among this high-risk population, we found
jective sonographic criteria at our institution, a forearm that a fistula was possible in only 39% (28% in the fore-
(radiocephalic) fistula was placed in 48% of the patients. arm and 11% in the upper arm), whereas 61% required
An additional 29% of the patients received an upper a graft [13].
arm fistula (brachiocephalic or brachiobasilic), because
Patient demographicsa forearm fistula was not feasible. Thus, some type of
native fistula could be constructed in 77% of patients, The likelihood of having a fistula placed can vary sub-
and only 23% received an A-V graft [13]. Miller et al stantially among different patient subgroups (Table 4).
could place a fistula in 76.5% of patients, including 42% Numerous studies have reported that fistula placement
in the forearm and 34.5% in the upper arm [34]. Dixon, is less frequent among women than men, and a few recent
Novak and Fangman reported that a fistula was possible studies suggest that fistula placement is less likely among
black than white patients. We found that female genderas a primary access in 73% of patients (36% in the fore-
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FACTORS AFFECTING FISTULA MATURATION
Adequacy of vessels and type of fistula
Several changes are critical for the successful matura-
tion of a new fistula [36]. First, it must dilate to a caliber
large enough to be cannulated repeatedly with two large-
bore dialysis needles. Second, the blood flow rate in the
draining vein must increase sufficiently to accommodate
the dialysis blood flow required to deliver adequate dial-
ysis. To avoid vein collapse and recirculation, the access
blood flow should exceed the desired dialysis blood flow
by at least 100 mL/min. The mean dialysis blood flow
varies substantially among countries: about 400 mL/min
in the United States, 300 mL/min in Europe, and 200
mL/min in Japan (abstract; Dykstra et al, J Am Soc
Nephrol 11:182A, 2000). All other factors being equal,
this means that patients in Europe and Japan require
substantially longer dialysis times than American dialysis
patients to achieve comparable Kt/V values. These dif-
ferences also mean that the definition of a mature fistula
can vary among countries. A fistula that is deemed ade-
quate in Japan or Europe when it delivers a dialysis
blood flow of 200 to 300 mL/min may be considered
inadequate in the United States. Using ultrasounds of
fistulas obtained one to four months postoperatively, we
observed that 40% of fistulas had an access flow rate
500 mL/min [37]. Clearly, a lower proportion of such
fistulas would be deemed adequate for dialysis in the
U.S., as compared with Europe or Japan. Third, the wall
of the draining vein must hypertrophy sufficiently to seal
after withdrawal of the dialysis needle. Finally, the fistula
must be superficial enough for the landmarks to be ap-
preciated and permit safe cannulation without infiltration.
Fig. 7. Brachiobasilic transposition A-V fistula.
There is marked variation in the published literature
regarding the definition of a “successful” fistula. The
definitions have included presence of a thrill or bruit,
ability to use the fistula for at least one dialysis session,and black race were independent predictors of a lower
or ability to use the fistula reproducibly for dialysis forlikelihood of fistula placement. Using objective preoper-
at least one month with a dialysis blood flow 350 mL/ative vascular measurements, a fistula could be placed
min. Not surprisingly, the adequacy rate of fistulas isin only 43% of black women, as compared with 92% of
lower when a more stringent definition is used. Fistulaswhite men [13].
have a relatively high rate of primary failure (Table 2),Moreover, the initial fistula is more likely to be placed
due to either early thrombosis or failure of the draining
in the upper arm, rather the forearm, when the patient
vein to dilate adequately to mature, that is, be cannulated
is female or black. Using objective preoperative sono- and provide a reasonable dialysis blood flow reproduci-
graphic criteria, we found that the initial fistula place- bly. In the absence of preoperative vascular mapping,
ment was in the upper arm in 64% of women, as com- the rate of primary failure may be substantially higher
pared with 36% of men. Similarly, fistula construction in forearm, as compared to upper arm fistulas. We re-
in the upper arm occurred in 54% of black patients, as ported a primary failure rate of 66% in forearm fistulas,
compared with 34% of whites [13]. as compared with 41% among upper arm fistulas [25].
The effect of diabetic status on fistula placement is Similarly, Hakaim, Nalbandian and Scott observed a
controversial. Whereas some studies have observed sub- 70% non-maturation rate for forearm fistulas among dia-
stantially lower fistula placement in diabetic, as com- betic dialysis patients, as compared with 22% for upper
pared with non-diabetic patients, other investigators arm fistulas [38]. Finally, Bender, Bruyninckx and Gerlag
reported a primary one-year patency of 76% in forearmhave found little or no difference (Table 4).
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Table 4. Likelihood of fistula (rather than graft) placement by clinical characteristics
Gender Race Diabetic status
Citation Female % Male % Ratio Black % White % Ratio Yes % No % Ratio
Winsett, 1985 [66] 13 25 0.52
Kherlakian, 1986 [21] 40 59 0.68 46 51 0.90
Churchill, 1992 [67] 51 74 0.69 64 66 0.97
Coburn, 1994 [20] 48 61 0.79 58 53 1.09
Rocco, 1996 [23] 40 72 0.56 47 68 0.69 41 61 0.67
Miller, 1999 [25] 22 44 0.50 27 36 0.75
Sedlacek, 2001 [43] 66 60 1.10
Oliver, 2001 [12] 41 65 0.63 55 68 0.81 46 78 0.59
Allon, 2001 [13] 50 74 0.68 54 86 0.63 63 65 0.97
fistulas, as compared with 93% among upper arm fistulas were useable for dialysis in only 7% of women, 12% of
elderly patients, and 20% of diabetics. In contrast, the[39]. A deliberate policy at one center of placing upper
arm fistulas in preference to forearm fistulas resulted in respective maturation rates of upper arm fistulas for
these patient subsets were 56%, 54%, and 48%, respec-a substantial increase (from 28 to 44%) in the prevalence
of patients dialyzing with fistulas [40]. tively [25]. When we began using objective sonographic
vascular mapping to guide access placement, we discov-There are contradictory conclusions as to whether the
outcomes of secondary fistulas are different from those ered that vessels suitable for construction of a forearm
fistula were less likely among women and blacks [13].of primary fistulas. Using preoperative sonographic vas-
cular mapping, we observed similar maturation rates of Once we began using routine preoperative vascular
mapping to assist the surgeons in planning vascular ac-primary and secondary fistulas (53 vs. 54%) [13]. In con-
trast, Gibson et al reported that primary access failures cess, we found no association between patient age, race,
diabetic status or body mass index and the likelihood ofwere about 40% lower among primary than secondary
fistulas [35]. fistula maturation. On stepwise logistic regression analy-
sis, female sex was the only independent predictor ofSeveral small European studies have observed a lower
decreased likelihood of fistula maturation [13]. In agree-rate of early fistula thrombosis among patients treated
ment with these observations, Sedlacek et al observedwith anti-platelet agents started preoperatively and con-
similar maturation rates of fistulas among diabetic andtinued for three to six weeks [41]. A large prospective,
non-diabetic patients [43].randomized study is clearly warranted to address this
important clinical question.
Patients are frequently encouraged to perform regular
FACTORS AFFECTING LONG-TERM PATENCYhand exercise to promote maturation of a new fistula. There
OF MATURE FISTULASis no published research confirming the efficacy of this
Type of fistulamaneuver. The only study addressing this question failed
to demonstrate a significant increase in A-V fistula flow Dixon et al observed superior one-year primary pat-
during hand exercise in 40 patients with renal failure [42]. ency (62 vs. 44%) and secondary patency (69 vs. 52%)
Finally, the experience of the surgeon is also an impor- of upper arm fistulas as compared with forearm fistulas
tant factor determining fistula outcome. Dixon, Novak [26]. The recent increase in utilization of brachiobasilic
and Fangman recently reported that fistula patency was transposition fistulas has led to studies comparing their
worse if it was placed by an inexperienced surgeon (12 outcomes to those of A-V grafts and brachiocephalic
access procedures) than if it was placed by an experi- fistulas. Coburn and Carney reported that the primary
enced surgeon [26]. Similarly, Pisoni et al found that patency at one year of brachiobasilic fistulas was 90%,
a successful fistula was less likely if a surgery trainee as compared with 70% of upper arm grafts [20]. More-
performed or assisted in the access procedure [18]. These over, the grafts had a complication rate 2.5-fold higher
findings suggest that vascular access surgery should be than the fistulas. The primary failure (lack of maturation)
restricted to surgeons with a strong interest and who rates are comparable for brachiobasilic and brachioceph-
perform a large number of access procedures. alic fistulas: 21 vs. 22% in one study [38], and 21 vs. 32%
in a second report [12]. Recently, Oliver et al compared
Patient demographics the survival of upper arm brachiocephalic fistulas, trans-
posed brachiobasilic fistulas, and upper arm grafts at oneFistula maturation varies substantially among differ-
ent demographic groups. Prior to the use of preoperative institution [12]. Excluding primary failures, thrombosis-
free survival at one year was 50% for grafts, 77% forvascular mapping, we found that new forearm fistulas
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Table 5. Overall success rate in achieving adequate (useable) fistulas when preoperative vascular mapping is used
Proportion of all Proportion of Proportion of all
patients with fistulas that patients with Fist prevalence
fistula placed were useable useable fistula in U.S., 1999
All patients 0.64 0.54 0.34 0.27
Sex
Female 0.50 0.44 0.22a 0.18
Male 0.74 0.60 0.44 0.35
Race
Black 0.54 0.54 0.29b 0.23
White 0.86 0.52 0.45 0.29
Age
65 years 0.62 0.42 0.26 0.23
65 years 0.64 0.56 0.36 0.31
Diabetes
Yes 0.63 0.49 0.31 0.22
No 0.65 0.59 0.38 0.30
First three columns are adapted from [13] and the last column from [16].
a P  0.001, bP  0.02
brachiobasilic fistulas, and 93% for brachiocephalic fistu- this advantage was limited to men younger than 72 years
of age. In agreement with these studies, Wolowczyk re-las. Thus, brachiobasilic fistulas were superior to synthetic
grafts, but inferior to brachiocephalic fistulas. Excluding ported that fistula patency was substantially worse in
women than in men [45].primary failures, the cumulative (assisted) survivals of
brachiobasilic and brachiocephalic fistulas were compa- Similarly, Gibson et al observed that the cumulative
rable to each other, and superior to that of A-V grafts access survival (time from access placement to perma-
(Fig. 1) [12]. When primary failures were included, the nent failure) was better for fistulas than for grafts [35].
cumulative survival was comparable for all three types Once again, the differences were not uniform on subset
of vascular access (Fig. 1). However, the intervention analysis. Thus, fistulas outperformed grafts in white men
rates per access-year to achieve long-term patency were and younger men, but were not clearly better in black
2.4 for grafts, 0.7 for brachiobasilic fistulas, and 0.4 for men and older men. A recent European study observed
brachiocephalic fistulas. a lower cumulative survival of fistulas as compared with
The DOPPS Study reported that primary patency of grafts among patients aged 70 or older [46].
fistulas was lower in the United States than in Europe (68
vs. 83%) [18]. The reason for this discrepancy remains
STRATEGIES TO INCREASE FISTULAto be elucidated, but possible explanations may include
PREVALENCE AMONG DIALYSIS PATIENTSdifferences in patient co-morbidity or skill of the dialysis
Taken together, the body of published literature sug-staff in fistula cannulation. In addition, the primary pat-
gests that the success rate of fistulas is not uniform amongency of fistulas was inferior among patients starting dial-
patient subgroups. When one considers all factors re-ysis with a catheter, as compared with patients who initi-
quired for the long-term success of fistulas, includingated dialysis therapy with a mature fistula [18].
placement, successful maturation, and need for subse-
Patient demographics quent salvage procedures, the likelihood of success varies
substantially among groups (Table 5). Specifically, theThe primary patency (time from placement to first
success rate of fistulas is less likely among women, blacks,intervention) of fistulas varies among different patient
and older patients. This suggests that even with optimalsubsets. Gibson et al reported that intervention-free sur-
efforts to maximize the use of fistulas, the success ratevival of fistulas was clearly better than that of grafts
among dialysis units may vary depending on patient char-for white men and younger men [35]. In contrast, the
acteristics. It is important to keep such differences indifferences between the primary patencies of fistulas and
mind when comparing vascular access prevalence amonggrafts were not significant among black men or older
dialysis units. For example, it is likely that units thatmen. Since this study was performed at a Veterans Hos-
dialyze men exclusively (such as Veterans Hospital-affil-pital, the investigators were unable to address potential
iated units) will have a higher than average proportiondifferences in fistula maturation between men and
of patients with fistulas. In contrast, units with largewomen. However, Astor et al reported that intervention-
black populations are likely to have a lower than averagefree survival was identical between fistulas and grafts
prevalence of fistulas. Notwithstanding these caveats,among female dialysis patients [44]. Primary access sur-
vival was superior for fistulas among male patients, but concerted and focused efforts should increase the preva-
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lence of patients dialyzing with fistulas at any unit, re- met minimum diameter criteria (2 mm for the artery and
gardless of the specific patient case-mix. 2.5 mm for the vein), there was no correlation between
vessel diameter and likelihood of fistula maturation [13].
A multidisciplinary approach to vascular access The mean artery and vein diameters during preoperative
Multiple individuals are involved in the management mapping are not significantly different between diabetic
of vascular access, including nephrologists, access sur- and non-diabetic patients. However, vascular calcifica-
geons, radiologists, dialysis nurses, and the patient. tions are more frequent among diabetics than non-dia-
Achieving optimal vascular access outcomes requires betics (64 vs. 35%) [43].
agreement on a common set of goals by all these individ- In one study preoperative vascular mapping limited
uals, close collaboration, and good communication [10]. the number of vessels and extremities available for vas-
A key feature of a successful multidisciplinary approach cular access placement in 66% (33 of 50) patients. Three-
to vascular access is having a dedicated access coordina- quarters of those patients had not had a previous vascular
tor who acts as a liaison between all the services involved, access. The most common abnormality observed was
schedules all access procedures, and maintains a compu- insufficient vein diameter [49]. We recently performed a
terized database. Prospective tracking of vascular access pilot study to evaluate the impact of routine preoperative
procedures and their complications is critical to evaluate sonographic vascular mapping on the surgeon’s choice
whether changes in practice patterns result in improved of access [50]. Seventy consecutive patients scheduled
outcomes. The multidisciplinary approach also can in- for construction of a permanent vascular access were
crease fistula placement in pre-dialysis patients by stream- enrolled. The criteria for placement of a fistula were
lining the referral process. defined prospectively, and included a minimum artery
diameter of 2 mm, a minimum vein diameter of 2.5 mm,Rationale for preoperative vascular mapping
and lack of stenosis or thrombosis in the draining vein
At most clinical centers, the surgeon decides what or central veins [51]. The surgeon initially determined
type of vascular access to place and at which anatomic what type of vascular access to place and at which loca-
location on the basis of physical examination alone, with tion, on the basis of a physical examination alone. Subse-
and without a tourniquet. This type of approach may quently, the surgeon reviewed the results of the preoper-
result in the use of inappropriate vessels for fistula con- ative vascular mapping, and was asked whether those
struction, or conversely, failure to recognize a vessel would change his intended surgical procedure. Preopera-
suitable for fistula construction. Some patients may ap- tive ultrasound mapping resulted in a change in the
pear to have an excellent vein with a suitable caliber on planned surgical procedure in 31% of the patients. In
inspection. However, sonographic evaluation may reveal
most cases, the surgeon decided to place a fistula, rather
an unsuspected stenosis or thrombosis in a more proxi-
than the planned graft, or to place the intended fistulamal portion of that vein, which would render that particu-
at a different anatomic location [50].lar vein unsuitable for construction of a fistula. In other
patients, physical examination may reveal no suitable Description of preoperative vascular
veins for construction of a fistula. Sonographic evalua- mapping procedure
tion, however, may reveal suitable veins that were simply
Vascular measurements are performed with the pa-too deep to appreciate clinically. Use of such veins may
tient in a seated position, with their arm resting comfort-require venous transposition procedures to ensure that
ably on a Mayo stand [50]. All measurements are in thethe fistula is superficial enough to be cannulated success-
anteroposterior dimension in the transverse plane. Thefully for dialysis.
minimum vein diameter for a native arteriovenous fistulaThe caliber of the vessels used for fistula construction
is 0.25 cm. The minimum vein diameter for graft place-is an important factor predicting the likelihood of its
ment is 0.40 cm. The minimum arterial diameter for eithermaturation. For example, Malovrh reported that the pat-
fistula or graft placement is 0.20 cm. Veins are assessedency rate of fistulas for dialysis at three months was just
for stenosis, thrombus and sclerosis (thickened walls).36% if the preoperative internal diameter of the artery
First, the radial artery diameter at the wrist is mea-was1.5 mm, but was 83% when this diameter was1.5
sured. A tourniquet is then placed at the mid to uppermm [47]. Moreover, the flow rates in the fistula were
forearm. The veins about the wrist are percussed for twohigher in the second group, as compared with the first
minutes, with special emphasis on the cephalic vein area.group. Similarly, Wong et al noted that if the artery or
Sequential measurements are made of the cephalic veinvein diameter was 1.5 mm, the fistula always failed to
at the wrist, mid and cranial forearm. Any other dorsalmature [48]. However, when the diameters were higher,
or volar veins at the wrist also are measured and followedit was not possible to predict on the basis of vessel diame-
up the arm, according to established diameter criteria.ter whether a given fistula would successfully mature.
Similarly, we found that as long as the artery and vein The tourniquet is sequentially moved up the arm, and
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Table 6. Effect of preoperative vascular mapping on vascular access outcomes
% Fistulas placed % Primary fistula failure % Prevalence of fistula use
Citation Pre-VM Post-VM Pre-VM Post-VM Pre-VM Post-VM
Silva, 1998 [51] 14 63 36 8 8 64
Ascher, 2000 [52] 0 100 N/A 18 5 68
Gibson, 2001 [35] 11 95 18 25 N/A N/A
Allon, 2001 [13] 34 64 54 46 16 34
Sedlacek [43] N/A 62 N/A 25 N/A N/A
Mihmanli, 2001 [53] 25 6
Miller, 1997 [34] N/A 76
Abbreviations are: VM, preoperative vascular mapping; N/A, not available.
cephalic, basilic, and brachial vein diameters are mea- las [51], two other reports observed only slight increases
or decreases in the primary failure rate (Table 6) [13, 35].sured.
After the tourniquet is removed, the subclavian and The net effect of preoperative vascular mapping was a
jugular veins are assessed for stenosis and thrombus. consistent increase in the prevalence of patients success-
Evidence of a more central stenosis is determined by fully dialyzing with fistulas. In three studies only 5 to
analysis of the spectral Doppler waveform for respiratory 16% of the patients were dialyzing with fistulas before
phasicity and transmitted cardiac pulsatility. implementation of routine preoperative vascular map-
Measurements are recorded on a worksheet. The so- ping; this proportion increased substantially (34 to 68%
nographic measurements are used by the surgeon to se- of patients) after introduction of such a program (Table
lect the most appropriate vascular access, on the basis 6). An additional study, which did not provide a historical
of the following list agreed upon by our nephrologists, control, reported that preoperative vascular mapping re-
radiologists and vascular surgeons, from most desirable sulted in 62% of patients receiving a fistula, and a 25%
to least desirable: primary failure rate [43]. Finally, a recent study from
Turkey observed a reduction of the non-maturation rate
1. Non-dominant forearm cephalic vein fistula of fistulas from 25 to 6% after implementing preopera-
2. Dominant forearm cephalic vein fistula tive vascular mapping [53].
3. Non-dominant, or dominant upper arm cephalic When preoperative vascular mapping is used to guide
vein fistula the surgeon, the inferior outcomes of forearm fistulas
4. Non-dominant or dominant upper arm basilic vein relative to upper arm fistulas were no longer observed.
transposition fistula Prior to the use of preoperative mapping, the maturation
5. Forearm loop graft rate at our center was 34% for forearm fistulas and 59%
6. Upper arm straight graft for upper arm fistulas [25]. With preoperative mapping,
7. Upper arm loop graft (axillary artery to axillary the respective maturation rates were 59 and 56%, respec-
vein) tively [13]. The improvement of forearm fistula adequacy
was particularly striking among women (from 7 to 36%)
Effect of preoperative vascular mapping on vascular and diabetic patients (from 21 to 50%). However, using
access outcomes these objective criteria, fistula placement was about one-
third less likely in women than men, and about one-thirdFour clinical studies have evaluated prospectively the
effect of instituting preoperative vascular mapping on less likely in black than white patients [13]. Thus, a fistula
was possible in 92% of white males, but only 43% ofvascular access outcomes [13, 35, 51, 52]. In each case,
using preoperative physical examination alone, only a black females. Similarly, Stehman-Breen et al reported
that the first permanent vascular access placed was lesssmall proportion of patients (0 to 34%) received a fistula,
rather than a graft (Table 6). Following introduction of likely to be a fistula in women, blacks, older patients,
diabetics, and obese patients [24]. About 46% of fistulasroutine preoperative vascular mapping, the proportion
of patients receiving fistulas increased to 63 to 100% placed with the benefit of preoperative vascular mapping
at our center were in the upper arm, rather than the(Table 6). Finally, a retrospective study reported that
a combination of preoperative venography and intra- forearm. Fistula construction was more likely to be in
the upper arm in women than men (64 vs. 36%), andoperative angioscopy resulted in fistula placement in
76% of patients [34]. The effect of such a program on more likely in blacks than whites (54 vs. 34%) [13]. Taken
together, these observations suggest that women andthe primary failure rate of fistulas constructed was incon-
sistent among studies. Whereas one study demonstrated black patients have smaller vessels.
Preoperative vascular information also can be ob-a substantial decrease in the primary failure rate of fistu-
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tained by venography. However, this approach suffers no instance should the initial cannulation be delegated
to a relatively inexperienced patient care technician.from several disadvantages. First, it evaluates just the
Fistula maturation is usually evaluated by subjectiveveins, not the arteries. Second, there is a risk of inducing
physical examination by the dialysis nurse or nephrolo-phlebitis, thereby jeopardizing the vein intended for fis-
gist. We recently correlated objective postoperative sono-tula construction. Finally, among patients not yet on
graphic measurements with clinical outcomes (adequacydialysis, exposure to radiocontrast dye may worsen the
for dialysis) of fistulas constructed after preoperativerenal failure and precipitate an earlier requirement for
vascular mapping [37]. When the ultrasound revealed adialysis. Digital subtraction venography with gadoterate
minimum vein diameter 0.4 cm or a blood flow ratemeglumine may provide comparable information to
500 mL/min, about 70% of the fistulas matured. If bothstandard venography without incurring the risk of neph-
criteria were met, the likelihood of fistula maturationrotoxicity, but is considerably more expensive than the
was 95%; however, if neither criterion was achieved, theuse of nonionic iodinated contrast agents [54]. Despite
likelihood of fistula adequacy for dialysis was only 33%.its shortcomings, venography is more sensitive than ul-
Female patients were less likely than males to achieve thetrasound for detection of stenosis or thrombosis in the
minimum vein diameter (40 vs. 69%). These observationscentral veins, and may have a role in selected patients
suggest that veins in women may be less likely to dilate,in whom there is a clinical suspicion for this problem.
thereby contributing to a 30% lower maturation rate,Sonography has, however, emerged as the method of
even when preoperative vascular mapping is used [13].choice for the preoperative assessment of the arteries
It would be helpful to identify the earliest time pointand veins to assist the surgeon in planning vascular access
at which subsequent maturation of a new fistula couldplacement.
be evaluated. This would result in either prompt inter-
vention to salvage an immature fistula or in timely place-Assessment of fistula maturation
ment of a new vascular access, if the existing fistula isIn spite of the use of preoperative sonographic data
not likely to mature. An increase in blood flow occursto select vessels suitable for fistula construction, some
very early after fistula construction. In one prospectivefistulas still fail to mature adequately for dialysis use.
study, the mean arterial inflow on preoperative evalua-There may be additional measurements obtained by pre-
tion was 30 mL/min. Within 24 hours of surgery, theoperative Doppler ultrasound that predict clinically suc-
fistula blood flow was up to 472 mL/min, and by onecessful fistulas. These type of evaluations have not been
week it had increased further to 861 mL/min [55]. Aaddressed systematically, but may include a change in
second prospective study observed a mean preoperative
Doppler flow signal after fist clenching [47] or a preoper-
arterial inflow of 47 mL/min, which increased to 184 mL/
ative subclavian venous flow rate 400 mL/min [55]. min at one day, 202 mL/min at one week, 488 mL/min
The expertise of dialysis nurses plays an important at eight weeks, and 562 mL/min at 12 weeks [47]. Retro-
role in the assessment and successful cannulation of new spective analysis from our institution found that the
fistulas. It is more technically challenging to cannulate blood flow was not significantly different in the second,
fistulas as compared with grafts. Experienced dialysis third, or fourth month following fistula construction (707,
nurses can successfully predict fistula maturation 80% 685, and 807 mL/min, respectively) [37]. Similarly, the
of the time [37]. New dialysis nurses require considerable minimum vein diameter was similar in the second, third,
practice and supervision before they become adept at and fourth months after fistula placement (0.45, 0.46,
assessing and cannulating new fistulas. Given the much and 0.39 cm, respectively) [37].
lower prevalence of fistulas among U.S. than European An early increase in access blood flow and vein diame-
dialysis patients, U.S. dialysis nurses also have fewer ter suggests that many fistulas could be cannulated suc-
opportunities to practice. Infiltration of new fistulas ap- cessfully within a few weeks of their construction. How-
pears to occur more commonly with fistulas than grafts; ever, in the United States the typical time interval from
when this occurs, there is a further delay in the successful fistula placement to its successful use for dialysis is two
use of a fistula for dialysis. Clearly, concerted efforts to to four months [12, 13, 26, 56]. New A-V fistulas are
enhance the proficiency of nurses in using fistulas for cannulated much earlier in Europe, as compared to the
dialysis is a critical element in increasing the prevalence United States. Cannulation of fistulas within one month
of patients dialyzing successfully with fistulas. During of their construction occurs 52% of the time in Europe,
the present transition phase, when the prevalence of but only 2% of the time in the United States. Moreover,
fistulas is increasing, it is extremely disappointing when there is no association between the time of first cannula-
a potentially functional fistula is compromised by lacera- tion and risk of fistula failure (abstract; Young et al, J
tion, infiltration, and serious hematoma at the time of Am Soc Nephrol 11:201A, 2000). The explanation for
its initial use. Perhaps formal certification of nurses for these striking practice differences among countries is
not apparent. The shorter time to fistula cannulation ininitial cannulation of fistulas should be considered. In
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Europe may contribute to the higher use of fistulas in gists and nephrologists become familiar and proficient
with the methodology of fistula thrombectomy.Europe at initiation of dialysis, but would not account for
Although the frequency is lower than with grafts, fis-the higher fistula use among prevalent dialysis patients.
tulas also are prone to developing stenotic lesions [11].
Salvage of immature fistulas Analogous to grafts, monitoring for hemodynamically
significant stenosis and elective angioplasty can reduceSome fistulas fail to mature due to unrecognized steno-
the frequency of fistula thrombosis. A program of vascu-sis in the draining vein, or large tributary veins that
lar access blood flow monitoring reduced the thrombosislimit the blood flow through the main draining vein. An
rate of fistulas from 0.14 to 0.07 events per access-yearaggressive approach to evaluating immature fistulas for
at one center [11]. The primary patency following angio-evidence of correctable abnormalities, with appropriate
plasty is similar for fistulas and grafts [11, 59]. McCarleyinterventions, can improve the maturation rate. Beath-
et al observed a median intervention-free survival afterard, Settle and Shields reported on their experience with
angioplasty of 161 days for fistulas and 148 days for grafts71 patients referred because of inadequate maturation
[11]. Similarly, Turmel-Rodrigues reported primary pat-of their fistulas [36]. Eight were not evaluated further
ency at six months after angioplasty to be 67% in fistulas,because they were believed to have an inadequate arte-
as compared with 53% in grafts [59].rial inflow. The remaining 63 patients underwent angio-
plasty of a stenotic lesion in the draining vein, ligation
of one or more tributary veins, or a combination of both DIFFERENCES BETWEEN VASCULAR ACCESS
procedures. As a result of these salvage attempts 82.5% IN THE U.S. AND EUROPE
of the fistulas matured adequately to be used for dialysis. The ongoing Dialysis Outcomes and Practice Patterns
In some cases surgical procedures may be helpful in Study (DOPPS) [17] has highlighted several significant
salvaging a fistula. For example, in some obese patients, differences in vascular access management in Europe,
a postoperative ultrasound may reveal a well-developed as compared with the United States. We have touched
fistula with an adequate diameter and blood flow that is on some of these findings in various parts of this review.
simply too deep to be cannulated. A second surgical It will be important to explore these differences in the
procedure to superficialize the fistula, by tunneling it future, so as to increase the prevalence of fistula use in
subcutaneously, can render the fistula accessible to the the U.S.
dialysis nurse [13].
1. The use of fistulas is much more common in EuropeSalvage of clotted and stenosed A-V fistulas
than the United States, whether one looks at inci-
Mature A-V fistulas are much less likely to clot than dent or prevalent patients [18]. Having more pa-
are grafts (Table 3). Unfortunately, when they do clot, tients with fistulas gives European dialysis nurses
thrombectomy is much more time-consuming and techni- more experience with cannulation of fistulas and
cally challenging for fistulas than grafts. Whereas declotting the interventionalists more experience with fistula
A-V grafts is a fairly standardized procedure, declotting salvage and interventions.
a fistula requires considerable ingenuity and improvisa- 2. Hemodialysis patients in Europe have lower co-
tion. Due to the low success rate of thrombectomy of morbidity than do patients in the United States
fistulas, most U.S. centers have abandoned efforts at this (Table 1) [18]. This difference may contribute, in
procedure, and simply proceed with placement of a new part, to the higher prevalence of fistulas among
vascular access once a fistula has clotted [11–13]. Some European dialysis patients, but is unlikely to ac-
of the difficulties encountered in declotting fistulas in- count by itself for the fourfold difference.
clude the thin venous wall, difficulty in localizing the 3. Fistulas in Europe are cannulated much earlier in
anastomosis, the multiple possible locations of stenosis, Europe than in the United States (abstract; Young
the frequency of encountering very tight stenoses, the et al, J Am Soc Nephrol 11:201A, 2000). The reasons
high frequency of venous aneurysms, and the large vol- for this difference are not evident, but the presence
ume of clot [57]. Two groups of European investigators of a large cadre of experienced dialysis nurses for
have recently reported good success rates in declotting initial cannulation may be a factor.
A-V fistulas, using creative and meticulous radiologic 4. Mean dialysis blood flows are substantially lower
techniques [57, 58]. The immediate technical success rate in Europe than in the United States (mean flow,
was about 90%, and the primary patency rate at six 300 vs. 412 mL/min; abstract; Dykstra et al, J Am
months was about 50% in both studies. The patency rate Soc Nephrol 11:182A, 2000). Accepting lower dial-
was much worse for upper arm fistulas than for forearm ysis blood flows may cause some fistulas to be con-
fistulas [57]. As the use of fistulas increases in the United sidered useable in Europe, whereas they would be
deemed inadequate in the United States.States, it will be imperative that interventional radiolo-
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lance of dialysis-associated diseases in the United States, 1997.5. European hemodialysis units have substantially
Semin Dial 13:75–85, 2000
higher staffing by registered nurses. Specifically, the 6. Schwab SJ: Vascular access for hemodialysis. Kidney Int 55:2078–
2090, 1999ratio of registered nurse to patient dialysis-hour
7. Schwab SJ, Raymond JR, Saeed M, et al: Prevention of hemodialy-was 38% higher in Europe than in the United States
sis fistula thrombosis. Early detection of venous stenosis. Kidney
(abstract; Mapes et al, J Am Soc Nephrol 12:337A, Int 36:707–711, 1989
8. Besarab A, Sullivan KL, Ross RP, Moritz MJ: Utility of intra-2001). More experienced nurses are likely to have
access pressure monitoring in detecting and correcting venous out-a higher success rate in cannulating fistulas.
let stenoses prior to thrombosis. Kidney Int 47:1364–1373, 1995
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